116 related articles for article (PubMed ID: 19633100)
1. Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
Smith K; Semple D; Bhandari S; Seymour AM
Eur J Heart Fail; 2009 Aug; 11(8):732-8. PubMed ID: 19633100
[TBL] [Abstract][Full Text] [Related]
2. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
[TBL] [Abstract][Full Text] [Related]
3. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
Tada H; Kagaya Y; Takeda M; Ohta J; Asaumi Y; Satoh K; Ito K; Karibe A; Shirato K; Minegishi N; Shimokawa H
Cardiovasc Res; 2006 Aug; 71(3):466-77. PubMed ID: 16781691
[TBL] [Abstract][Full Text] [Related]
4. Down-Regulation of Cardiac Erythropoietin Receptor and its Downstream Activated Signal Transducer Phospho-STAT-5 in a Rat Model of Chronic Kidney Disease.
Hertzberg-Bigelman E; Barashi R; Levy R; Cohen L; Ben-Shoshan J; Keren G; Entin-Meer M
Isr Med Assoc J; 2016 Jun; 18(6):326-30. PubMed ID: 27468524
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin and the heart: physiological effects and the therapeutic perspective.
Sanchis-Gomar F; Garcia-Gimenez JL; Pareja-Galeano H; Romagnoli M; Perez-Quilis C; Lippi G
Int J Cardiol; 2014 Feb; 171(2):116-25. PubMed ID: 24377712
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury.
van der Meer P; Lipsic E; Henning RH; de Boer RA; Suurmeijer AJ; van Veldhuisen DJ; van Gilst WH
Eur J Heart Fail; 2004 Dec; 6(7):853-9. PubMed ID: 15556046
[TBL] [Abstract][Full Text] [Related]
7. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.
Kobayashi H; Minatoguchi S; Yasuda S; Bao N; Kawamura I; Iwasa M; Yamaki T; Sumi S; Misao Y; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Tabata Y; Fujiwara H
Cardiovasc Res; 2008 Sep; 79(4):611-20. PubMed ID: 18541523
[TBL] [Abstract][Full Text] [Related]
8. Protective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice.
Asaumi Y; Kagaya Y; Takeda M; Yamaguchi N; Tada H; Ito K; Ohta J; Shiroto T; Shirato K; Minegishi N; Shimokawa H
Circulation; 2007 Apr; 115(15):2022-32. PubMed ID: 17404160
[TBL] [Abstract][Full Text] [Related]
9. [Pleiotropic effects of erythropoietin].
Kes P; Basić-Jukić N; Furić-Cunko V
Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
11. Novel renoprotective actions of erythropoietin: new uses for an old hormone.
Johnson DW; Forman C; Vesey DA
Nephrology (Carlton); 2006 Aug; 11(4):306-12. PubMed ID: 16889570
[TBL] [Abstract][Full Text] [Related]
12. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.
Copland IB; Jolicoeur EM; Gillis MA; Cuerquis J; Eliopoulos N; Annabi B; Calderone A; Tanguay JF; Ducharme A; Galipeau J
Cardiovasc Res; 2008 Aug; 79(3):405-15. PubMed ID: 18397963
[TBL] [Abstract][Full Text] [Related]
13. [Erythropoietin - state of science].
Schöffel N; Börger JA; Quarcoo D; Scutaru C; Groneberg DA
Sportverletz Sportschaden; 2008 Dec; 22(4):201-6. PubMed ID: 19085770
[TBL] [Abstract][Full Text] [Related]
14. Cardiac remodeling in response to chronic iron deficiency: role of the erythropoietin receptor.
Naito Y; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Morisawa D; Eguchi A; Hirotani S; Mano T; Tsujino T; Masuyama T
J Hypertens; 2015 Jun; 33(6):1267-75. PubMed ID: 25715089
[TBL] [Abstract][Full Text] [Related]
15. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
Miki T; Miura T; Yano T; Takahashi A; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Nishihara M; Naitoh K; Ohori K; Shimamoto K
J Pharmacol Exp Ther; 2006 Apr; 317(1):68-75. PubMed ID: 16377761
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin and renoprotection.
Bahlmann FH; Fliser D
Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):15-20. PubMed ID: 19077684
[TBL] [Abstract][Full Text] [Related]
17. Potential for erythropoietin synthesis in kidney of uraemic rat alters depending on severity of renal failure.
Sanada S; Toyama H; Ejima Y; Matsubara M
Nephrology (Carlton); 2009 Dec; 14(8):735-42. PubMed ID: 20025682
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
van der Putten K; Braam B; Jie KE; Gaillard CA
Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
Lipsic E; Schoemaker RG; van der Meer P; Voors AA; van Veldhuisen DJ; van Gilst WH
J Am Coll Cardiol; 2006 Dec; 48(11):2161-7. PubMed ID: 17161240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
